How to Test for Lymphedema: An Overview of Diagnosis

Lymphedema diagnosis typically begins with a physical exam and limb measurements, then moves to specialized imaging or bioelectric testing when the clinical picture is unclear or early detection matters. There is no single definitive test that catches every case. Instead, clinicians combine bedside findings, volume comparisons, and sometimes advanced imaging to confirm the diagnosis, stage severity, and rule out conditions that look similar.

The Physical Exam and the Stemmer Sign

The first thing most clinicians do is look and feel. They check for visible swelling, skin texture changes, and whether pressing a finger into the swollen area leaves a pit that fills back slowly. One well-known bedside test is the Stemmer sign: the examiner tries to pinch and lift a fold of skin at the base of the second toe (or second finger). If the skin is too thick and tight to pinch, the sign is positive and suggests lymphedema.

A study comparing the Stemmer sign against lymphoscintigraphy (the imaging gold standard for lymphatic function) found that a positive result correctly identified abnormal lymphatic drainage about 92% of the time. However, a negative result was less helpful: its specificity was only 57%, meaning nearly half of people with a negative Stemmer sign still had lymphatic problems on imaging.¹ In practical terms, a positive Stemmer sign is a strong pointer toward lymphedema, but a negative one does not rule it out, especially in early or mild cases where the skin has not yet thickened.

Measuring Limb Volume

Because lymphedema causes swelling, one of the most straightforward diagnostic approaches is comparing the volume of the affected limb to the unaffected side, or tracking changes in the same limb over time. A volume increase of 10% or more on the affected side is a widely used threshold, though some protocols flag increases as small as 5% for early intervention. Several methods exist to get these numbers, each with trade-offs in accuracy, cost, and convenience.

Water Displacement

Submerging the limb in a water-filled container and measuring the overflow is the most direct way to determine volume. It has long been considered a reference standard. One study of women with lymphedema found that water displacement measurements had high reliability, with correlation coefficients above 0.91 for both inter-rater and intra-rater comparisons.² The method is accurate, but it is also messy, time-consuming, and impractical for patients with open wounds or limited mobility. That is why most outpatient clinics rely on faster alternatives.

Circumferential Tape Measurement

This is the most commonly used method in everyday clinical practice. A clinician wraps a tape measure around the limb at set intervals, then plugs the circumferences into a formula to estimate volume. A recent comparison of circumferential techniques against water displacement found that both fixed-height and segmental tape methods tracked closely with actual limb volume, with median errors of roughly 1% or less.³ The catch is that the accuracy depends on consistent technique. Landmark-based measurements, where the tape is placed at anatomical landmarks rather than at fixed centimeter intervals, tend to perform better for detecting volume changes in the range clinicians care about.⁴

Perometry

A perometer is a device that uses infrared light to scan the limb and calculate its volume automatically. It is fast, usually taking under a minute, and highly repeatable. Test-retest reliability in one study was 0.99, and the measurement error was clinically acceptable.⁵ Perometry and tape measurement do not always agree perfectly, though. The same study found that tape measures overestimated lower-limb volume by an average of about 157 mL compared to the perometer. For clinical decisions, that gap matters less than consistency within the same method over time. What you want is to track the same patient with the same tool at each visit.

Bioimpedance Spectroscopy for Catching Lymphedema Early

One of the bigger shifts in lymphedema care has been the push toward early detection, particularly in breast cancer survivors who are at risk after surgery or radiation. Bioimpedance spectroscopy, often called BIS, sends a weak electrical current through the limb and measures how the tissue resists it. Fluid-filled tissue conducts electricity differently than normal tissue, so the device can pick up excess fluid before the swelling is visible or the patient notices symptoms.

BIS readings are expressed in L-Dex units, with a score around zero being normal. Research has supported using an absolute value of 7 or more L-Dex units as indicative of early clinical lymphedema, representing about two standard deviations above the normative mean. A randomized trial evaluating BIS-guided early intervention modified its subclinical detection threshold to 6.5 L-Dex units, placing it just below the clinical threshold to allow for preventive treatment before full-blown lymphedema sets in.⁶ The appeal of BIS is that it can detect fluid changes months before a tape measure would flag a volume difference, opening a window for compression garments or manual therapy to prevent progression.

Tissue Dielectric Constant Measurements

Another approach to measuring tissue water is the tissue dielectric constant, or TDC. A handheld probe placed on the skin sends a low-frequency electromagnetic signal and measures how the tissue responds. Because the signal is sensitive to water content, it reflects how much fluid is sitting in the skin and just below it.⁷

TDC has an advantage over BIS and volume measurements in that it can assess very localized areas. If swelling is concentrated in the hand, the breast, or the trunk rather than distributed along an entire arm, TDC can zero in on that spot. This makes it particularly useful for breast cancer-related lymphedema, which does not always present as arm swelling. It can also affect the chest wall, the breast itself, or the trunk.⁸ One study of women treated for breast cancer found that TDC detected arm lymphedema earlier after surgery and at a lower arm volume than water displacement did, and concluded it was the more valid early-detection method of the two.⁹

Self-Reported Symptom Questionnaires

Patients often notice something is off before a measurement confirms it. Heaviness, tightness, aching, or a sense that clothing or jewelry fits differently can precede measurable swelling. Several validated questionnaires try to capture these sensations systematically. The Lymphedema and Breast Cancer Questionnaire (LBCQ) and the Gynecological Cancer Lymphedema Questionnaire (GCLQ) are among the most studied, both showing high reliability in research settings.¹⁰

These tools work well for screening and for tracking how patients feel over time, but they are not substitutes for objective measurement. When the LBCQ was compared against perometry, it correctly identified only about 41% of lymphedema cases that the perometer flagged. Specificity was better at 80%, meaning most people without lymphedema correctly reported no symptoms. Still, fewer than half of objectively confirmed cases were caught by self-report alone.¹¹ The takeaway is that symptom questionnaires are useful additions, especially for prompting further workup, but relying on them alone would miss a majority of early cases.

Lymphoscintigraphy

When clinicians need to see the lymphatic system itself, rather than just measuring its downstream effects, lymphoscintigraphy is the traditional imaging choice. A small amount of radioactive tracer is injected under the skin, usually between the toes or fingers, and a gamma camera tracks how the tracer moves through the lymphatic channels and into the lymph nodes. The resulting images show how quickly fluid travels, whether the expected lymph nodes light up, and whether tracer leaks backward into the skin, a pattern called dermal backflow.

Radiologists score these images using a transport index based on five criteria: how fast the tracer moves, the pattern of any dermal backflow, how quickly lymph nodes appear, how many nodes are visible, and whether the lymphatic vessels themselves can be seen.¹² Lymphoscintigraphy is especially valuable when the diagnosis is uncertain, when the cause needs clarification, or when surgery is being considered. It is also used to distinguish true lymphedema from conditions that mimic it, such as swelling caused by obesity or venous insufficiency, which produce different tracer patterns.

Indocyanine Green Lymphography

A newer imaging approach uses indocyanine green (ICG), a fluorescent dye injected just under the skin. A near-infrared camera then tracks the dye as it moves through superficial lymphatic channels in real time. Unlike lymphoscintigraphy, which requires a nuclear medicine department, ICG lymphography can be performed in an office or operating room and provides immediate, dynamic images.

The patterns that show up on ICG imaging correlate with severity. In mild cases, the dye traces a clear linear path along the lymphatic channels. As lymphedema worsens, the pattern shifts to dermal backflow, which researchers have classified into three progressively severe types: splash, stardust, and diffuse.¹³ The same staging system has been validated in lower-extremity lymphedema as well.¹⁴ Surgeons rely heavily on these patterns when planning procedures like lymphatic-venous anastomosis, because the backflow maps show exactly where functioning channels remain and where the damage is worst.

ICG lymphography has also been adapted for less typical locations. A protocol developed for head and neck lymphedema, which can occur after cancer surgery involving neck dissection, uses four injection sites to map drainage toward the upper cervical, submandibular, and submental nodes. In healthy volunteers, three expected drainage pathways appeared on the same side as the injection. In people who had undergone neck dissection, the imaging revealed dermal backflow and two rerouted drainage pathways toward the paraspinal and armpit regions.¹⁵

Ultrasound, MRI, and CT Lymphangiography

Conventional imaging tools also play a role. High-frequency ultrasound can assess the tissue just beneath the skin, looking for changes characteristic of lymphedema. One approach evaluates two parameters: how bright (echogenic) the subcutaneous layer appears, and whether echo-free spaces, which represent pockets of fluid, are visible.¹⁶ Ultrasound is inexpensive and widely available, making it a practical option for monitoring tissue changes over time without radiation exposure.

MRI and CT offer more detailed cross-sectional views. Magnetic resonance lymphangiography can visualize lymphatic channels and nodes in high resolution, and a dynamic contrast-enhanced version has been applied to diagnose central lymphatic flow disorders, including unusual presentations like chylothorax or protein-losing enteropathy. These advanced applications are less about diagnosing straightforward limb lymphedema and more about mapping complex or atypical lymphatic problems that need surgical planning or are poorly explained by other tests.

Telling Lymphedema Apart from Similar Conditions

Lower-limb swelling in particular has a long list of possible causes, and several of them overlap with lymphedema clinically. Chronic venous insufficiency can produce swelling, skin changes, and discomfort that look a lot like lymphedema. Lipedema, a condition involving abnormal fat distribution, causes bilateral leg enlargement that can be mistaken for lymphedema. Obesity itself can impair lymphatic drainage and cause swelling that meets some lymphedema criteria. And combinations of these problems are common, with terms like phlebolymphedema used when venous disease and lymphatic impairment coexist.

Imaging helps sort these apart. Lymphoscintigraphy produces different tracer patterns depending on whether the primary problem is lymphatic, venous, fat-related, or a combination. Someone with pure lipedema, for instance, may have relatively normal lymphatic transport on imaging despite significant leg enlargement, while someone with true lymphedema will show delayed transport and dermal backflow. The distinction matters because treatments differ: compression and surgical lymphatic procedures work for lymphedema, while lipedema may respond better to specialized liposuction, and venous insufficiency requires its own set of interventions.

Genetic Testing for Primary Lymphedema

When lymphedema develops without an obvious trigger like cancer surgery, infection, or trauma, the condition is classified as primary lymphedema and may have a genetic basis. Genetic testing panels are available to look for mutations in genes associated with lymphatic development. In practice, however, the yield is low. A study of 147 people clinically diagnosed with primary lymphedema found that established genetic tests returned a positive result in only 11 cases. The majority were either negative or inconclusive.¹⁷

This does not mean the lymphedema is not genetic in those negative cases. It more likely means that the genes and pathways involved have not all been identified yet, and current test panels only cover a fraction of them. Genetic testing is most useful when there is a family history of lymphedema or when the presentation is congenital, because a confirmed mutation can sometimes guide prognosis and inform family planning. For the majority of people with primary lymphedema, though, the diagnosis still rests on clinical assessment and imaging rather than a blood test.

Emerging Biomarkers

Researchers are working on blood-based tests that could flag lymphedema risk before any swelling occurs. An animal study found that levels of two molecules changed in the blood before visible lymphedema developed: hyaluronic acid (HA) rose while leukotriene B4 (LTB4) dropped. The ratio of LTB4 to HA emerged as the strongest predictor of lymphedema development, with lower ratios corresponding to worse outcomes.¹⁸ These findings have not yet been validated in large human trials, so a blood test for lymphedema risk remains a research prospect rather than a clinical reality. But the concept is appealing, particularly for breast cancer patients who could be screened with a simple blood draw at follow-up visits.

How Staging Systems Relate to Testing

Once lymphedema is confirmed, clinicians assign a stage to describe severity. The International Society of Lymphology (ISL) staging system, the most widely used, runs from stage 0 (subclinical, with impaired lymphatic transport but no visible swelling) through stage III (severe, with hardened tissue and skin changes). Staging guides treatment decisions: early stages may respond to compression and manual therapy, while advanced stages may need surgery.

Different diagnostic tools do not always agree on severity, which can complicate clinical decision-making. A study comparing ISL clinical staging, ICG lymphography staging, and preoperative volume measurements in over 200 patients found only moderate correlation between them. ISL stage and volume difference correlated reasonably well, but ICG stage and ISL stage had a weaker relationship.¹⁹ This makes sense when you consider what each tool measures: volume tells you how much swelling there is, clinical staging incorporates tissue quality and pitting, and ICG staging reflects the microscopic pattern of lymphatic flow. A limb can have extensive dermal backflow on ICG imaging but relatively modest volume increase, or vice versa. Using multiple assessment methods gives a fuller picture than any single test.

When and Why Testing Sequences Differ

Not everyone with suspected lymphedema goes through the same diagnostic pathway. For a breast cancer survivor whose arm starts swelling six months after surgery, the cause is usually obvious, and the workup may be as simple as tape measurements confirming a volume increase. For someone with unexplained bilateral leg swelling, the path is longer: venous duplex ultrasound to rule out clots or venous insufficiency, possibly lymphoscintigraphy to check lymphatic function, and perhaps blood work and imaging to exclude other medical causes of edema like heart failure, kidney disease, or low protein levels.

Insurance coverage and equipment availability also shape what tests get ordered. BIS devices and perometers are not available in every clinic. ICG lymphography requires a near-infrared camera and trained interpretation. Lymphoscintigraphy is only performed at facilities with nuclear medicine capabilities. In many community settings, the diagnostic process comes down to a careful physical exam, circumferential tape measurements compared side to side or over time, and clinical judgment. The more advanced tests add precision and are especially important before surgery, but the basic tools remain the backbone of lymphedema diagnosis for most patients.